Fineline Cube

Follow:
14398 Articles
Beijing Aosaikang Pharmaceuticals Boosts Stake in US Subsidiary AskGene with RMB 220 Million Investment
CompanyDeals

Beijing Aosaikang Pharmaceuticals Boosts Stake in US Subsidiary AskGene with RMB 220 Million Investment

Eli Lilly China Appoints Yan Qiong as Vice President of Diabetes Business Unit
Company

Eli Lilly China Appoints Yan Qiong as Vice President of Diabetes Business Unit

Shanghai Releases Local Guidelines to Correct Unhealthy Practices in Pharmaceutical Procurement and Medical Services
Policy / Regulatory

Shanghai Releases Local Guidelines to Correct Unhealthy Practices in Pharmaceutical Procurement and Medical Services

InnoCare Pharma Achieves Positive Phase II Results for TYK2 Inhibitor ICP-488 in Psoriasis Treatment
CompanyDrug

InnoCare Pharma Achieves Positive Phase II Results for TYK2 Inhibitor ICP-488 in Psoriasis Treatment

Ascletis Pharma's ASC40 Earns FDA Breakthrough Therapy Designation for Fibrotic MASH
CompanyDrug

Ascletis Pharma’s ASC40 Earns FDA Breakthrough Therapy Designation for Fibrotic MASH

HitGen Inc. Partners with Ablink Biotech to Develop Antibody-Oligonucleotide Conjugates
CompanyDeals

HitGen Inc. Partners with Ablink Biotech to Develop Antibody-Oligonucleotide Conjugates

Sichuan Biokin's BL-B01D1 Earns Breakthrough Therapy Designation for Esophageal Cancer from China's CDE
CompanyDrug

Sichuan Biokin’s BL-B01D1 Earns Breakthrough Therapy Designation for Esophageal Cancer from China’s CDE

Merck's Keytruda Meets Primary Endpoint in Phase III Study for Head and Neck Cancer
CompanyDrug

Merck’s Keytruda Meets Primary Endpoint in Phase III Study for Head and Neck Cancer

Boehringer Ingelheim's Survodutide Earns FDA Breakthrough Therapy Designation for MASH Treatment
CompanyDrug

Boehringer Ingelheim’s Survodutide Earns FDA Breakthrough Therapy Designation for MASH Treatment

Eli Lilly Appoints Thomas J. Fuchs as First Chief AI Officer to Lead AI Initiatives
Company

Eli Lilly Appoints Thomas J. Fuchs as First Chief AI Officer to Lead AI Initiatives

Zephyrm Bioscience Limited Files for IPO on Hong Kong Stock Exchange
CompanyDeals

Zephyrm Bioscience Limited Files for IPO on Hong Kong Stock Exchange

Pfizer Halts Development of Sisunatovir, an RSV Antiviral, After Phase II/III Trials
CompanyDrug

Pfizer Halts Development of Sisunatovir, an RSV Antiviral, After Phase II/III Trials